Study identifies benefit of donor SCT for adults with acute myeloid leukaemia

A stem cell transplant (SCT) from a compatible donor early in the course of disease is the best approach for the majority of young and middle-aged adult patients with acute myeloid leukaemia (AML), according to a new analysis of two dozen clinical studies...

Read the whole article on

More from